Trials / Terminated
TerminatedNCT05820997
Paravertebral Block vs no Block in Open Pancreaticoduodenectomy
Paravertebral Block vs no Block in Open Pancreaticoduodenectomy: Prospective Randomized Controlled Trial
- Status
- Terminated
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 2 (actual)
- Sponsor
- Mayo Clinic · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to compare intra and postoperative pain control between Paravertebral block vs no block in open pancreaticoduodenectomy. Length of stay, and complications will also be recorded. For this study the investigator plans to randomize to obtain objective data for clinical decisions and improve patient outcomes. Following surgery patients in both groups, data will be collected from the first 48 hours after surgery and at discharge.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Ropivacaine | Paravertebral at the T7-10 levels bilaterally with 5 cc of 0.5% ropivacaine at each level |
Timeline
- Start date
- 2023-04-24
- Primary completion
- 2024-12-04
- Completion
- 2024-12-04
- First posted
- 2023-04-20
- Last updated
- 2025-12-16
- Results posted
- 2025-12-16
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT05820997. Inclusion in this directory is not an endorsement.